President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Known as GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback